Genfit S A Asset Turnover Ratio (GNFT), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Genfit S a   (NASDAQ: GNFT)
 

Genfit S A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Genfit S A asset turnover ratio, the ability of Genfit S A 's assets to generate revenue in the fourth quarter 2024, increased sequentially to 0.47 in the fourth quarter (Dec 31 2024), yet the ratio remained below the average, as GNFT's position remain challenging.

Within sector Genfit S a achieved the highest asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2024, to 1, from total ranking in the third quarter 2024 at 4.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GNFT Asset Turnover Ratio (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Asset Change -12.91 % -12.91 % -12.91 % -12.91 % -19.33 %
Y / Y Revenue Change 85.82 % - - - 43.7 %
Asset Turnover Ratio (TTM) 0.47 - - - 0.22
GNFT's Total Ranking # 1 # 4 # # #
Seq. Asset Change 0 % 0 % 0 % -12.91 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 1
Overall Market # 1

Asset Turnover Ratio Statistics
High Average Low
21394.75 11249.13 1939.5
(Dec 31 2021)   (Dec 31 2020)




GNFT Company Profile • Back to GNFT Efficiency Comparisons • Compare GNFT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024
Rigel Pharmaceuticals Inc  1.28 $ 179.278  Millions$ 139.581  Millions
Docgo Inc   1.28 $ 616.555  Millions$ 482.089  Millions
Infusystem Holdings Inc  1.28 $ 134.861  Millions$ 105.574  Millions
Electrocore Inc   1.25 $ 24.397  Millions$ 19.440  Millions
Ardent Health Inc   1.25 $ 5,966.072  Millions$ 4,774.091  Millions
Nephros Inc   1.24 $ 13.723  Millions$ 11.028  Millions
Koru Medical Systems Inc   1.23 $ 33.646  Millions$ 27.353  Millions
Henry Schein Inc   1.23 $ 12,673.000  Millions$ 10,304.750  Millions
Xtant Medical Holdings Inc   1.23 $ 117.216  Millions$ 95.557  Millions
Aveanna Healthcare Holdings Inc   1.22 $ 2,024.506  Millions$ 1,653.744  Millions
Warby Parker Inc   1.22 $ 770.834  Millions$ 631.395  Millions
Qhslab Inc   1.22 $ 2.132  Millions$ 1.748  Millions
Hca Healthcare Inc   1.21 $ 70,603.000  Millions$ 58,328.250  Millions
Evofem Biosciences Inc   1.20 $ 19.363  Millions$ 16.125  Millions
Indivior Pharmaceuticals Inc   1.19 $ 2,078.000  Millions$ 1,745.500  Millions
Mettler toledo International Inc   1.18 $ 3,872.361  Millions$ 3,273.027  Millions
Electromed Inc   1.18 $ 59.626  Millions$ 50.571  Millions
Nuwellis Inc   1.18 $ 8.662  Millions$ 7.361  Millions
Exagen Inc   1.17 $ 55.112  Millions$ 47.102  Millions
Vaso Corporation  1.16 $ 86.767  Millions$ 74.597  Millions
Pro dex Inc   1.16 $ 61.003  Millions$ 52.453  Millions
Idexx Laboratories Inc  1.16 $ 3,896.927  Millions$ 3,353.148  Millions
Evolus Inc   1.16 $ 266.274  Millions$ 230.531  Millions
Trisalus Life Sciences Inc   1.15 $ 29.328  Millions$ 25.442  Millions
Dynatronics Corporation  1.15 $ 29.933  Millions$ 26.134  Millions
Sunshine Biopharma Inc   1.15 $ 34.874  Millions$ 30.454  Millions
Nrc Health  1.13 $ 143.060  Millions$ 126.087  Millions
Neuraxis Inc   1.13 $ 2.686  Millions$ 2.370  Millions
Phibro Animal Health Corporation  1.13 $ 1,105.115  Millions$ 977.423  Millions
Reshape Lifesciences Inc  1.13 $ 7.057  Millions$ 6.258  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.